In case you missed our scientific talk, simply contact us!
High-throughput workflows for isolation of antigen-specific B-cells and validation of drug candidates
Kathrin Dienst, PhD, Bucher Biotec AG, CH
About the conference:
Benefitting from tremendous advances in large-scale ‘omics’ technologies, immune phenotyping and genome engineering, novel integrated workflows are providing unprecedented insights into the networks, pathways and systems that govern human health and disease, thus enabling their successful therapeutic manipulation.